Navigation Links
Hard To Treat Diseases (HTDS) Equipment Purchase, and General Update on its Cancer and Anti Aging Projects
Date:9/10/2009

BELGRADE, Serbia, Sept. 10 /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com The company is pleased to announce that its operating subsidiary Slavica Bio Chem www.slavicabiochem.com has acquired new equipment for its research work.

    The equipment is accessory mini Protean Tetra System from BioRad.
   http://www.expressionproteomics.com/LifeScience/pdf/Bulletin_3095.pdf

Dr.Ivana Gadjanski HTDS Medical Liaison Correspondent said: "To our followers who are interested in what this apparatus does in summary, Mini Protean Tetra System is a system for 2D electrophoresis which can be used for Western blotting. The new system runs both hand cast gels and Ready Gel Precast Gels interchangeably. The new apparatus will significantly enhance the sample processing procedure. The cell can run one or four gels, and the mini tank is compatible with other Bio-Rad electrode modules for tank blotting, 2D electrophoresis and electroelution".

In other company news, the company has received several unsolicited proposals from other medical companies for its rights in the cancer research and anti aging projects. The company is also considering a merger proposal of its cancer research and anti aging project only, and the positive impact and values this exercise may bring upon the whole organization.

Originally the details were very sketchy and not worth mentioning in a news release or a filing. Over time this began to crystallize and now the company is of the opinion that this is a becoming a significant event, which its shareholders and followers should be made aware of.

The company has scheduled October 7 to October 11 as a date to review, and discuss the split off, sale or merger of its cancer research and anti aging projects and expects to make an announcement on this topic shortly thereafter.

The company will provide further updates on the aforementioned merger / sale of its cancer research and anti aging projects via Pink Sheets filing service with any operational updates in order to keep its followers informed.

More updates on other business activities of Slavica Bio Chem and Mellow Hope the company's China based operations will follow shortly and on a timely basis.

Safe Harbor Statement

Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. HTDS Corporation cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases, Inc.'s control. In addition to those discussed in Hard to Treat Diseases, Inc.'s press releases, public filings, and statements by Hard to Treat Diseases, Inc.'s management, including, but not limited to, Hard to Treat Diseases, Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases, Inc.'s ability to raise additional capital to fund future operations, HTDS Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard to Treat Diseases, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: For medical and scientific dialogue inquiry only, please contact medicalinfo@htdsmedical.com; For any corporate matters, please contact www.minamargroup.com/helpdesk


'/>"/>
SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Closing the Addiction Treatment Gap (CATG) Statement on Annual National Survey on Drug Use and Health Data Released by the Substance Abuse and Mental Health Services Administration (SAMHSA)
2. Video: Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering Ones Risk of Infection During Treatment
3. New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting-Edge Treatment to Satellite Communities
4. Treating Workers Mental Woes May Boost Productivity
5. Three Million Cases of Major Depressive Disorder Have Comorbid Panic Attack and Are Untreated in the U.S.
6. QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena(TM) (Ospemifene Tablets) in Treatment of Postmenopausal Vaginal Atrophy
7. GENova files patent for new breast cancer treatment
8. New Study a 'Wake Up Call' For the Urgent Need for Sleep Apnea Treatment
9. SEIU Local 721 Calls for Attorney General to Investigate Self-Dealing and $22 Million in Extra Costs at Tarzana Treatment Center
10. Wed., Sept. 16, 11 AM News Conference: Sioux Falls Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Celebrating Recovery Against New Wave of Drug Abuse; Former U.S. Drug Czar/4-Star Gen. Barry McCaffrey, Lieute
11. Hard to Treat Diseases, Inc. (HTDS) and Landstar Inc (LDSR) Retain Auditors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... , ... Valentine’s Day is nearly upon us, and most singles could probably ... flawless hair, and a sparkling personality are all well and good, but if somebody ... home with Rover. (Actually, man’s best friend might not even want to be near ...
(Date:2/13/2016)... ... February 13, 2016 , ... In its newly ... vein visualization technology should be used to ensure patient safety when placing an ... INS Standards mandate the use of vein visualization technology in patients with difficult ...
(Date:2/12/2016)... ... 12, 2016 , ... According to an article published February 4th ... significant portion of hernia repairs throughout the United States. Commenting on this article, Beverly ... that this trend has not only been expected, but it seems to be a ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a ... closed for the ISE Southeast Awards 2016. Finalists and winners of the ISE® ... Southeast Executive Forum and Awards Gala on March 15, 2016 at the Westin ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... February 12, 2016 ... vermerkt)   http://www.sedar.com ) und ... abrufbar.    --> http://www.sedar.com ... http://www.telestatherapeutics.com abrufbar.    --> ... heute seinen Konzernabschluss des zweiten Quartals ...
(Date:2/12/2016)...  Memorial Hermann Health System has teamed up with ... bring a one-of-a-kind experience to pediatric patients at ... as 360-degree video and Google Cardboard, Howard was able ... giving the patients and their families an unexpected, and ... on video . Memorial Hermann IRONMAN ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
Breaking Medicine Technology: